Related Experiment Video
Updated: Sep 12, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Expanding the Genotypic and Phenotypic Spectrum of P3H1 Related Osteogenesis Imperfecta
Erdem Kındış1, Enise Avcı Durmuşaliğlu2, Elif Eviz3
1Medical Genetics Clinic, Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey. erdem9217@gmail.com.
Abstract:
Osteogenesis Imperfecta (OI) is a genetically heterogeneous disorder with a clinical spectrum ranging from mild to severe. Biallelic P3H1 (OMIM*610339) variants are generally associated with a severe recessive phenotype. This study reports six individuals from three families with phenotypic variability and two novel variants, aiming to expand the phenotypic and genotypic spectrum of P3H1-related OI. The six patients from three unrelated families exhibited varying severity of P3H1-related OI. In Family 1, three siblings, all homozygous for the recurrent c.446 T > G (p.Leu149Arg) variant, showed marked phenotypic differences. One presented with a deforming phenotype, while the other two had milder forms with fewer fractures and little to no skeletal deformity. In Family 2, the affected individual had neonatal fractures and was compound heterozygous for a novel splice-site variant (c.1171-2_1171-1delinsC) and a missense change previously classified as variant of uncertain significance (VUS) (c.1224G > C; p.Lys408Asn). The variants were segregated confirming compound heterozygosity. In Family 3, two siblings with neonatal fractures were homozygous for a novel 58 bp deletion in exon 15 (c.2112_2169del; p.Glu708AlafsTer21), with both parents identified as carriers. This study expands the P3H1 genotypic spectrum with two novel variants and provides evidence supporting reclassification of c.1224G > C as likely pathogenic based on the updated PM3 criterion. It highlights phenotypic variability in patients with the same variant and suggests mild phenotypes may be seen in patients with certain P3H1 variants.
More Related Videos
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
09:20Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Related Concept Videos
Pleiotropy
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pedigree Analysis
Incomplete Dominance